Making decisions about antithrombotic therapy in heart disease. Decision analytic and cost-effectiveness issues

Chest. 1995 Oct;108(4 Suppl):457S-470S. doi: 10.1378/chest.108.4_supplement.457s.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Clinical Trials as Topic
  • Cost-Benefit Analysis
  • Decision Support Techniques*
  • Decision Trees
  • Fibrinolytic Agents / economics
  • Fibrinolytic Agents / therapeutic use*
  • Heart Diseases / drug therapy*
  • Heart Diseases / economics
  • Humans
  • Sensitivity and Specificity

Substances

  • Fibrinolytic Agents